Coeliac disease: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• JAK 0
• TNF 0
• NLRP3 0
• NRF2 0
• STAT3 0
• TLR4 0
• BDNF 0
• BTK 0
• FOXP3 0
• G6PD 0
• IL-15 0
• IL-6 0
• mTOR 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIGMS · F32

  Understanding the Roles of Glycosylated RNA Species in Homeostasis and Human Disease

  Rice University· Houston, Egyesült Államok· 76 300 USD awarded in fiscal year 2026· until 2029. szept.

• NIH NIDDK · R01

  Longitudinal analysis of T-B cell interactions and clonal dynamics to identify immune programs controlling tissue damage and healing in celiac disease

  University of Chicago· Chicago, Egyesült Államok· 819 998 USD awarded in fiscal year 2026· until 2030. jún.

• NIH NIDDK · DP1

  Redefining the Biogeography and Function of Food Proteins in Human Health and Disease

  Boston Children's Hospital· Boston, Egyesült Államok· 831 433 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIDDK · R01

  The role of microbiota specific T cells in Inflammatory Bowel Disease

  Icahn School of Medicine at Mount Sinai· New York, Egyesült Államok· 726 142 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIGMS · K99

  Harnessing Hydrophobic Interactions for Photocaging and Photoproximity Labeling

  University of California, San Diego· La Jolla, Egyesült Államok· 125 000 USD awarded in fiscal year 2026· until 2028. júl.

• European Commission (Horizon Europe) · HORIZON-ERC

  Exploring the dynamics of the gastrointestinal tract using shed cell and spatial transcriptomics (GI-DYNAMICS)

  Weizmann Institute of Science· Rehovot, Izrael· EU contribution 2 500 000 EUR· until 2030. nov.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Molecular chirality tools for the study of Gluten Immunogenic Peptides and Celiac Disease: Novel therapeutic and diagnostic approaches. (GLUCHIRAL)

  Universidad de Sevilla· Sevilla, Spanyolország· EU contribution 226 441 EUR· until 2028. febr.

• European Commission (Horizon Europe) · HORIZON-ERC

  Tracking gluten immunoreactive peptides from the grain to the gut and beyond (GLUTENOMICS)

  Leibniz-Institut Fuer Lebensmittel-Systembiologie An Der Technischen Universitaet Muenchen· Freising, Németország· EU contribution 1 499 988 EUR· until 2027. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology (geneTIGA)

  Charite - Universitaetsmedizin Berlin· Berlin, Németország· EU contribution 6 393 734 EUR· until 2026. dec.· 8 countries

  The disease is named only in the funder's project summary, not in the title.

9 of 74 running projects, newest first. Listed amounts together: 42,0 M USD + 10,6 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Organoids 2
• Mendelian Randomization Analysis 13
• CRISPR-Cas Systems 2
• Gene Expression Profiling 3
• Proteomics 8
• Metabolomics 4
• Mass Spectrometry 2
• Flow Cytometry 3
• Immunohistochemistry 7
• Magnetic Resonance Imaging 4
• Machine Learning 4
• Deep Learning 3
• Cohort Studies 25
• Genome-Wide Association Study 14

• Proteomic Analysis Highlights Peculiar Protein and Phosphoprotein Profiles in Dermal Fibroblasts from Celiac Disease Patients.

  Int J Mol Sci, 2026. ápr.

• Antigenic proteins of Lactobacillus acidophilus that are recognised by serum IgG antibodies in children with type 1 diabetes and coeliac disease.

  Pediatr Allergy Immunol, 2009. júl.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.